A review of American pharmacy: education, training, technology, and practice by unknown
REVIEW Open Access
A review of American pharmacy: education,
training, technology, and practice
Scott J. Knoer1, Allison R. Eck2* and Amber J. Lucas3
Abstract
In the United States, pharmacists are responsible for the provision of safe, effective, efficient, and accountable
medication related-care for hospital and health-system patients. Leveraging automated technologies, pharmacy
technicians, and pharmacist extenders are the means through which efficient, effective, and safe medication use
processes are created and maintained. These strategies limit the amount of pharmacist resources needed for
nonjudgmental tasks such as medication distribution, allowing more capacity for advanced direct patient care roles.
Pharmacists are directly integrated into interprofessional medical teams. Pharmacists optimize patient outcomes
through a variety of channels, including: providing recommendations for evidence-based medication selection on
patient care rounds; offering drug information to other health care providers and patients; monitoring therapeutic
responses; and reconciling medications as patients transition across the continuum of care.
Achieving the highest level of pharmacy practice necessitates that United States pharmacists are soundly educated
and trained. Pharmacist education, training, and professional practice models closely mirror those of physicians.
Many health-systems also pursue credentialing and privileging of pharmacists to ensure competency and facilitate
growth and development. Advanced training, along with credentialing, privileging, and collaborative practice
agreements have positioned pharmacists to serve as stewards of the medication use system, champions of patient
safety, and essential contributors to optimal patient outcomes.
Keywords: Pharmacist education, Pharmacist training, Professional practice, Practice model, Technology, Pharmacy
enterprise
Background
The United States’ (U.S.) healthcare system has under-
gone significant reform in the 21st century. Focus on
cost-effective care in pay-for-performance models has
accelerated the need for hospitals and health-systems to
achieve positive patient outcomes through leveraging the
most appropriate resources. This shift is reflected in the
practice of pharmacy with enhanced emphasis on phar-
macists managing medication use across the continuum
of patient care.
The American Society of Health-System Pharmacists
(ASHP) Pharmacy Practice Model Summit of 2011
stated that “pharmacists are responsible for the provision
of safe, effective, efficient, and accountable medication
related-care for hospital and health-system patients” [1].
Leveraging automated technologies, pharmacy techni-
cians, and pharmacist extenders are the means through
which efficient, effective, and safe medication use pro-
cesses are created and maintained. These strategies limit
the amount of pharmacist resources needed for nonjudg-
mental tasks such as medication distribution, allowing
more capacity for advanced direct patient care roles.
Achieving the highest level of pharmacy practice ne-
cessitates that U.S. pharmacists are soundly educated
through Doctor of Pharmacy, residency, and certification
programs. Many health-systems also pursue credential-
ing and privileging of pharmacists to ensure competency
and facilitate growth and development. Advanced training,
along with credentialing, privileging, and collaborative
practice agreements have positioned pharmacists to serve
as stewards of the medication use system, champions of
patient safety, and essential contributors to optimal pa-
tient outcomes.
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Pharmacist education, training, credentialing, and profes-
sional practice models closely mirror those of physicians
in the U.S. In parallel to the physicians’ clinical Doctor of
Medicine (M.D.) degree, pharmacists complete a univer-
sity clinical degree program at the Doctor of Pharmacy
(Pharm.D.) level. In 2000, the Pharm.D. became the exclu-
sive entry-level degree conferred upon graduating phar-
macists. The Pharm.D. is a four year professional degree
program completed after a minimum of two years of pre-
requisite undergraduate coursework. However, some U.S.
colleges of pharmacy require an additional level of course-
work and completion of a baccalaureate degree prior to
admission to pharmacy school.
The Pharm.D. curriculum consists of didactic and ex-
periential education that meets the standards set by the
Accreditation Council for Pharmacy Education (ACPE).
ACPE released new curriculum standards in July 2016.
This was a result of ongoing efforts to incorporate
advances in real-world pharmacy practice with more
focus on patient-centered care, interprofessional teams,
evidence-based practice, quality improvement, and
informatics [2].
The didactic curriculum of Pharm.D. education in-
cludes a foundation of pharmacy science courses such
as pharmacokinetics, pharmacology, medicinal chemistry,
and pharmacotherapy. Additional didactic curriculum is
also taught in areas such as medication safety, phar-
macy law and ethics, biostatistics, toxicology, epidemi-
ology, hands-on skill-based labs, evidence-based practice,
innovation, and business management.
The practical curriculum incorporates multiple experi-
ential elements. These include the newly added Interpro-
fessional Education (IPE) requirement, as well as the
traditional Introductory Pharmacy Practice Experiences
(IPPE) and Advanced Pharmacy Practice Experiences
(APPE). IPE experiences incorporate pharmacy student in-
teractions with other healthcare providers and students in
simulations or real-time scenarios such as patient rounds
with the medical team. IPPE rotations are two to four
week experiences in both community and hospital phar-
macy settings scheduled in the middle of the didactic cur-
riculum. These rotations help students grow by applying
knowledge in different areas of practice.
APPE rotations are four to six weeks in length and
are scheduled after the completion of didactic training
in the last year of the Pharm.D. curriculum. Goals of
APPE rotations include: 1) focusing the majority of
time on the provision of direct patient care, 2) gaining
experience treating diverse patient populations, 3) en-
gaging in collaborative patient-care decision-making
with members of an interprofessional healthcare team,
4) demonstrating competence in community, ambulatory
care, health-system pharmacy, and general medicine, and
5) allowing students to explore areas of interest and gain
exposure to professional opportunities [2].
Successful completion of both the didactic and prac-
tical pharmacy curriculum prepares a student to apply
for pharmacist licensure.
Pharmacist licensure
Pharmacist licensure and re-licensure is governed at the
state level by individual Boards of Pharmacy. Licensure
indicates that state requirements to practice pharmacy
are met. Candidates for licensure in all states must pass
the North American Pharmacist Licensure Examination
(NAPLEX). This competency-based examination applies
knowledge gained in pharmacy education to real-life
practice situations. All states also require a law examin-
ation incorporating both federal and state laws. Most
utilize the Multistate Pharmacy Jurisprudence Examin-
ation (MPJE) adapted with state-specific laws, rules, and
regulations as they apply within that state’s Pharmacy
Practice Act. Re-licensure by state boards of pharmacy
occurs after pharmacists complete ongoing require-
ments, which usually include a specific number of hours
and type of continuing education and verification that
the pharmacist is in good legal standing.
Traditional pharmacy professional development in the
U.S. has consisted of continuing education hours required
by most states to maintain licensure [3]. As the profession
becomes increasingly complex, ongoing education is shift-
ing to a more robust, continuous professional develop-
ment (CPD) model. CPD is defined as an ongoing self-
directed, structured, outcomes-focused cycle of learning
and personal improvement [4].
As scope of pharmacy practice evolves with more
complex roles and responsibilities in patient care, the
traditional model of learning is changing with it. To
ensure quality patient care, advanced training and certi-
fications that are voluntarily achieved by pharmacists are
starting to become required in many practice settings.
Newer models of competency-based education incorpor-
ate application of knowledge and demonstration of skills
in both controlled and real-life situations [5].
Post-graduate training
Post-graduate residency training, similar to physician
residency training, is becoming a required credential for
entry-level health-system pharmacy practice. More spe-
cialized clinical practice positions may require additional
specialty residency training. Completion of an accredited
residency program is a credential that differentiates
pharmacists from the general requirements for licensure.
A Post-Graduate Year One (PGY-1) residency program
is the baseline of residency training. It is a 12 month
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organized, directed, accredited program that builds upon
knowledge, skills, attitudes and abilities gained from
pharmacy school [6]. It is designed to enhance general
competencies in managing medication use systems and
supports optimal medication therapy outcomes for pa-
tients with a broad range of disease states.
A Post-Graduate Year Two (PGY-2) residency program
is also 12 months in length and builds on the competen-
cies achieved in a PGY-1 residency [7]. It is often referred
to as a specialty residency as its focus is within a specific
area of pharmacy practice, such as oncology, pediatrics,
ambulatory care, or management. A PGY-2 residency in-
creases the depth of knowledge related to medication
therapy and clinical leadership in the specific area of focus.
Graduates of a PGY-2 program are prepared to pursue
Board Certification if it exists in that specialty.
Fellowships are directed, highly-individualized, post-
graduate programs designed to prepare the participant to
become an independent researcher. Fewer of these oppor-
tunities exist compared to residency programs. This is
often the path pursued for new graduates interested in
practicing in the pharmaceutical industry or academia.
Advanced certification
Board certification through the Board of Pharmaceutical
Specialties (BPS) is a credential required or preferred in
advanced practice settings. Certification for pharmacists is
in alignment with physician certification through the
American Board of Medical Specialties [8]. The BPS has
recognized several domains of critical skills necessary for
advanced practice in different disease states and patient
populations [9]. By developing validated certification
exams, this credential has become the gold standard of ad-
vance practice qualification. For each recognized specialty,
BPS forms a Specialty Council of content experts and
psychometric consultants to develop test questions with
real-life practice relevance. Once certification is achieved
through the exam process, knowledge and skills are main-
tained through recertification every seven years.
BPS certifications for pharmacists today include ambu-
latory care, critical care, nuclear pharmacy, nutrition sup-
port, geriatrics, oncology, pediatrics, pharmacotherapy,
and psychiatric pharmacy. Added qualifications are avail-
able in infectious disease and cardiology.
Pharmacists can also acquire other less intensive certi-
fications and certificate programs that are available to
multiple disciplines and not pharmacist-specific. These
certifications are typically received after a short focused
training course and are available in specialty areas such
as anticoagulation, asthma, diabetes, pain management,
sterile product preparation, and advanced cardiac life
support.
Post-graduate residency training in a program accre-
dited by ASHP and specialty certification through the
BPS are supported by several professional pharmacy or-
ganizations [10, 11]. ASHP’s accreditation program and
the BPS serve as the most recognized advanced pharma-




Healthcare reform in the U.S. has accelerated the mergers
of smaller hospitals into large complicated multi-hospital
health-systems. These unions are created so that organiza-
tions can achieve operational and clinical efficiencies of
scale [12]. Today’s health-systems often include a broad
array of services in both the inpatient (acute hospital) and
outpatient (ambulatory or clinic) environment. Pharmacy
must connect the dots of these disparate segments and
oversee medication use across all sectors of patient care.
Optimizing patient outcomes and financial success by
managing all aspects of the medication use continuum in
an organization is referred to as leading the pharmacy
enterprise [13].
In the U.S., pharmacy practice is rooted in safe, efficient
medication distribution models. In hospitals, intravenous
medications are compounded centrally in pharmacies in
accordance with United States Pharmacopeia (USP) 797
guidelines. In July 2018, the compounding and handling
of hazardous medications will be similarly regulated by
USP chapter 800. USP 797 and 800 promote best practices
for safety in sterile and hazardous medication compound-
ing and are legally required by most state boards of phar-
macy [14].
Technology and automation are used throughout the
medication use process in healthcare facilities. Medications
are barcoded and barcode scanning is used for inventory
stocking, dose preparation, repackaging, dispensing,
and administration. Barcode technology enhances pa-
tient safety and the quality of care by improving accur-
acy and limiting human error [15, 16]. In addition to
barcode scanning, automation such as dispensing and
IV robots, carousels, automated dispensing cabinets,
and IV compounding software contribute to safe and
efficient medication distribution.
Pharmacy technicians
Well-educated and highly skilled pharmacy technicians
are an integral part of hospitals and health-systems.
Technicians perform most non-judgmental tasks under
the direction of a pharmacist, such as preparing, com-
pounding, and delivering medication; and managing
pharmacy automation. Advanced pharmacy technicians
perform additional tasks such as obtaining patients’
medication histories, inventory management, quality im-
provement initiatives, and working in advanced medica-
tion systems including tech-check-tech models [17].
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Although pharmacy technicians are certified by a na-
tional Pharmacy Technician Certification Board (PTCB),
the requirement for registration or licensure and the
scope of their responsibilities are set by individual state
laws, which vary widely. Joint efforts by the National As-
sociation of Boards of Pharmacy (NABP), ACPE, and
ASHP will elevate training and certification standards
for pharmacy technicians at a national level. Beginning
in 2020, PTCB will require new candidates for certifica-
tion to complete an ASHP/ACPE-accredited pharmacy
technician education program [18]. Driving toward a na-
tional standard for pharmacy technician education, certi-
fication, and registration/licensure will expand the scope
of technician practice, allowing for further reallocation
of pharmacist resources to direct patient care and ad-
vanced practice [19, 20].
Pharmacist extenders
Training of student and resident pharmacists is an import-
ant responsibility of health-system pharmacists. As greater
emphasis is placed on providing cost-effective services,
extra activities assumed by pharmacy must be associated
with measurable improvements in patient outcomes.
Leveraging pharmacist extenders creates opportunity for
expanded direct patient care activities in a manner that is
cost-effective while contributing to meaningful student
and resident learning experiences. This is commonly im-
plemented through a layered learner model [21].
The layered learner model consists of pharmacists pre-
cepting pharmacy residents, who teach and precept
pharmacy students to deliver direct patient care beyond
the reach of what the pharmacist could achieve alone
[22]. The layered learner model allows for pharmacy ser-
vices such as medication histories and reconciliation, fa-
cilitating bedside delivery of discharge medications, and
patient education on new and high risk medications.
These increased opportunities for patient interaction
contribute to a higher quality of patient care for a
greater number of patients and lead to increased patient
satisfaction [23].
Clinical initiatives
In hospitals, pharmacists are directly integrated into inter-
professional medical teams. Pharmacists optimize patient
outcomes through a variety of channels, including: provid-
ing recommendations for evidence-based medication se-
lection on patient care rounds; offering drug information
to other health care providers and patients; monitoring
therapeutic responses; and reconciling medications as pa-
tients transition across the continuum of care [24].
Pharmacists also direct medication use in health-
systems through involvement in pharmacy and therapeu-
tics (P&T) committees. The P&T Committee is a medical
and pharmacy group that is responsible for selecting and
managing the formulary, which is a list of institutionally
approved medications available in a hospital. This com-
mittee oversees policies governing the use of medications
through the development of medication guidelines, order
sets, and care pathways. The P&T committee may also
supervise the credentialing and privileging of the pharma-
cists employed by the health-system [25].
Credentialing and privileging
Credentialing has been used in the medical profession
for many years and is gaining recognition and accept-
ance in pharmacy. Credentialing is a process used by or-
ganizations to validate professional licensure, clinical
experience and other requirements for a specialized
practice. It consists of documentation of qualifications
that are expected of a healthcare provider to practice in
a specific setting [26]. As scope of pharmacy practice
evolves, the credentialing process must adapt to verify a
pharmacist’s ongoing competence to provide specific
pharmacy services. Competence assessment is an on-
going process. Credentialing of pharmacists to establish
competence and privileges for advanced practice is cur-
rently the responsibility of the organization the individ-
ual works for. Professional pharmacy organizations and
the Council on Credentialing in Pharmacy are working
to establish guidance and standards for advanced clinical
pharmacy practice [27]. It is anticipated that the latter
will serve to guide credentialing committees to better
understand pharmacy’s credentials and the systems by
which credentials are issued.
Privileging, which is used extensively for physicians, is the
process that defines a specific service provided by a health-
care practitioner. It ensures the individuals being granted
privileges within a healthcare organization are competent
and capable of performing certain activities [26].
Future direction
Population health
Due to historical financial payment models and incen-
tives, the U.S. healthcare system has focused primarily
on providing acute care instead of wellness and pre-
ventative care. The American healthcare system is the
best in the world for treating complex medical condi-
tions, such as uncontrolled diabetes and mental health
diagnoses [28, 29], and performing cutting-edge surgical
processes, such as face transplants [30]. However, the
U.S. lags many developed countries in terms of popula-
tion health management (PHM). Population health is
defined in the American Journal of Public Health as,
“the health outcomes of a group of individuals, including
the distribution of such outcomes within the group” [31].
Due to its historical lack of focus on PHM, the U.S. trails
many developed countries in patient outcomes including
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infant mortality, immunization status, morbidity from
chronic diseases, and overall life expectancy [32].
As a result of the unsustainable trajectory of health-
care spending in the U.S., payment models are moving
toward a more population health focused system. As
health-systems are financially incented to keep patients
healthy, organizations are transitioning to models more
adept at PHM. Pharmacists, and their ability to impact
cost and outcomes through effectively managing the
medication continuum across levels and sites of care, are
critical to the success of the healthcare system [33].
Collaborative practice
In order for our organizations to succeed in global pay-
ment, “at risk” and PHM models, all caregivers in the
health-system must be utilized to their full potential in
a cost-effective strategy. Ensuring that healthcare pro-
viders are optimized in a multi-disciplinary care team is
referred to as practicing at the “top of license.” Physi-
cians must focus on tasks requiring their unique skills
including diagnosing patients and leading the rest of
the care-team. Nurses must focus on providing nursing
care, dieticians must administer to a patient’s nutri-
tional needs and social workers must address the psy-
chosocial needs of the patient.
Pharmacists in the U.S. are increasingly recognized by
a broad array of stakeholders as the medication use ex-
perts in Patient Centered Medical Home and other
interdisciplinary care team models [34–39]. In order to
maximize patient outcomes, pharmacists must accept
accountability for managing medication use across the
care continuum. Once the physician diagnoses the pa-
tient, the pharmacist is increasingly responsible for
medication selection, patient education, monitoring, and
modifying drug therapy. Pharmacists are best able to
manage patient’s medication therapy through collabora-
tive practice agreements.
Collaborative practice is loosely defined as a pharma-
cist or group of pharmacists entering into an agreement
with a physician or group of physicians which allows the
pharmacist to manage patient medication therapy on the
physician’s behalf. Pharmacists’ ability to practice within
these agreements varies widely from state to state [40].
As mentioned previously, pharmacy practice is gov-
erned at the state level. The most advanced pharmacy
practice occurs in states with liberal collaborative prac-
tice laws. In these states, pharmacists can add, modify,
and discontinue medications and order appropriate la-
boratory tests.
Provider status, a financial barrier to pharmacist expansion
While pharmacists are advancing their ability to legally
practice at a high level state by state, one of the biggest
barriers to aggressive expansion of pharmacy services in
the ambulatory clinic domain is the inability of pharma-
cists to charge federal healthcare programs (Medicare
and Medicaid) for their services. Pharmacists are not
recognized as “providers” under Section 1861 of the So-
cial Security Act [41]. Not being listed among accepted
practitioners such as physicians, nurse practitioners, and
physician assistants limits pharmacists’ ability to gener-
ate revenue for the services they provide.
Because nurse practitioners and physician assistants
are recognized and can bill for services, they are much
more numerous in outpatient settings than are pharma-
cists. ASHP and the American Pharmacists Association
are actively pursuing provider status through the federal
legislative process.
Extended training and ever-evolving opportunities
A PGY-1 pharmacy residency is seen as the baseline for
working within the acute hospital and ambulatory clinic
setting. Completing a PGY-2 specialty residency and
achieving board certification is increasingly becoming a
requirement for working in specialized areas. As more
pharmacists achieve advanced training and as our patient
care becomes even more complicated, there is growing
debate around the potential need for PGY-3 residencies in
sub-specialties which would mimic the advancement of
physician training. Potential sub-specialties include ad-
vanced heart failure and cardiac transplantation, allergy /
immunology, bone marrow transplant, endocrine, diabetes
and metabolism, gastroenterology, maternal-fetal medi-
cine, medical toxicology, neonatology, neurology and
pediatric hematology / oncology [42].
Conclusions
The U.S. system for educating, training, licensing, certify-
ing, credentialing, and continually assessing pharmacists
has undergone dramatic changes over the last twenty
years. A key driver of this increased level of educational
sophistication was the requirement of the all Pharm.D.
curriculum. The expansion of and move toward requiring
residency training and board certification has continued
to advance the level of care that pharmacists provide in
the U.S.
Evolution of payment models that reward cost effective
resource utilization as opposed to over-treatment pro-
vides opportunities for pharmacists to positively impact
the healthcare system and to improve population health.
As enabling Collaborative Practice Acts and provider
status recognition progress, pharmacists will make an
increasingly positive contribution to the health of the
patients and communities they serve.
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